0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Digitalis Update

William Shapiro, MD
Arch Intern Med. 1981;141(1):17-18. doi:10.1001/archinte.1981.00340010019004.
Text Size: A A A
Published online

Are physicians prematurely condemning digitalis because the "drug lag" has created a hunger for new cardiovascular agents? Advances in clinical science do require continued refinement of indications and use of the digitalis glycosides. The classic indication for universal prescription, "congestive heart failure," must be more finely tuned.1 When the etiologic determinants of failure are pulmonary, endocrine, hypertension, mechanical, or muscle replacement, considerable evidence indicates that digitalis will be slightly effective or ineffective. But when affliction of left ventricular myocardium is the principal culprit, the weight of scientific evidence supports the therapeutic efficacy of the digitalis glycosides.2

Studies not yet carried out will compare the relative merits of other modes of therapy with digitalis for immediate and long-term effects, morbidity, and mortality. Afterload reduction has been impressive, particularly in subsets of patients shown to respond poorly to digitalis therapy. Whether these new agents will be as convenient and effective

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();